Equities analysts forecast that Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) will announce $8.26 million in sales for the current quarter, according to Zacks Investment Research. Five analysts have provided estimates for Marinus Pharmaceuticals’ earnings. The lowest sales estimate is $2.10 million and the highest is $32.00 million. The firm is scheduled to announce its next quarterly earnings […]
